Ageing Demographics And Personalised Medicine Will Boost Diagnostic Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
10 Jul 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
AU$4.76
43.0% undervalued intrinsic discount08 Aug
AU$2.71
1Y
6.7%7D
-3.2%